Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
Bausch Health (NYSE:BHC) announced that management will participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference in Austin, Texas on Tuesday, May 19, 2026 at 10:25 a.m. U.S. ET.
Rhea-AI Summary
Bausch Health (NYSE:BHC) announced that management will participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference in Austin, Texas on Tuesday, May 19, 2026 at 10:25 a.m. U.S. ET.
A live webcast and replay will be available on the company’s investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BHC
On May 13, the first trading day after this news, BHC closed 2.22% below the previous close.
Data tracked by StockTitan Argus for the May 13 session.
Key Figures
- Conference edition
- 30th Annual
- Barclays Leveraged Finance Conference
- Conference date
- May 19, 2026
- Barclays Leveraged Finance Conference participation
- Chat time
- 10:25 a.m. U.S. ET
- Scheduled fireside chat start time
Historical Context
-
Reported higher revenue with major goodwill impairment and reaffirmed 2026 guidance.
-
U.S. online launch of Biafine Skin Recovery Emulsion via multiple channels.
-
Announced date and time for first quarter 2026 financial results and call.
-
Launched 2026 ASPIRE HIGHER scholarships up to $10,000 each for six students.
-
Introduced Clear + Brilliant Touch laser in Canada after Health Canada approval.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
leveraged finance financial
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Details
Date: Tuesday, May 19, 2026
Time: 10:25 a.m.
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the event will be available on the investor relations website following the event.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll free) | (908) 569-3692 |
BHC-FINANCIAL |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-in-barclays-30th-annual-leveraged-finance-conference-302770033.html
SOURCE Bausch Health Companies Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
